Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      KKR will buy Envision Healthcare for 5.57 billion dollar plus debt

      KKR will buy Envision Healthcare for 5.57 billion dollar plus debt

      Ruby Khatun Khatun13 Jun 2018 9:45 AM IST
      Private equity firm KKR & Co. will buy Envision Healthcare Corp. for $5.57 billion plus debt, after a lengthy sale process by the hospital...
      Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ

      Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ

      Ruby Khatun Khatun13 Jun 2018 9:30 AM IST
      Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street Journal reported on Monday, a...
      Wearable medical device to treat drug addiction: Chennai firm Bags USFDA clearance

      Wearable medical device to treat drug addiction: Chennai firm Bags USFDA clearance

      Ruby Khatun Khatun12 Jun 2018 4:32 PM IST
      CHENNAI: The U.S. Food and Drug Administration (USFDA) has cleared an auricular neurostimulation device manufactured by a Chennai company to treat the...
      Cipla, Unitaid ink pact to cut price of HIV drug

      Cipla, Unitaid ink pact to cut price of HIV drug

      Ruby Khatun Khatun12 Jun 2018 10:30 AM IST
      Geneva/New Delhi: Drug major Cipla and Switzerland-based Unitaid have inked a pact under which the Indian drug major would reduce the price of a...
      Fortis board defers approving financial results again

      Fortis board defers approving financial results again

      Ruby Khatun Khatun12 Jun 2018 10:15 AM IST
      New Delhi: Fortis Healthcare on Monday said its board has again deferred approval of quarterly and annual financial results for the period ended March...
      Alembic Pharma gets USFDA nod for anti-depression drug

      Alembic Pharma gets USFDA nod for anti-depression drug

      Ruby Khatun Khatun12 Jun 2018 10:00 AM IST
      New Delhi: Alembic Pharmaceuticals has received the US health regulator's nod for Bupropion Hydrochloride tablets, used for the treatment of the major...
      User ratings for mobile medical apps may be misleading

      User ratings for mobile medical apps may be misleading

      Ruby Khatun Khatun12 Jun 2018 9:45 AM IST
      Washington: High "star rating" of medical apps does not necessarily reflect accuracy or value, say scientists who warn users to not trust such...
      Allergan oral migraine drug succeeds in study

      Allergan oral migraine drug succeeds in study

      Ruby Khatun Khatun12 Jun 2018 9:30 AM IST
      Allergan Plc said its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache...
      How to Rationalise trade margins in medical devices: NITI Ayog asks public for comments

      How to Rationalise trade margins in medical devices: NITI Ayog asks public for comments

      Ruby Khatun Khatun11 Jun 2018 5:32 PM IST
      Stakeholders can submit their comments or suggestions by 15 June 2018 at medical.devices.consultation@gmail.com.New Delhi: Niti Aayog has released...
      Cipla targets 1-billion dollars revenues from domestic market in FY19

      Cipla targets 1-billion dollars revenues from domestic market in FY19

      Ruby Khatun Khatun11 Jun 2018 10:30 AM IST
      Country's fourth-largest drug maker Cipla is bullish on growth and is looking for a billion dollar consolidated revenue for the domestic market in...
      Complex generics, biosimilars and specialty to be growth drivers: Lupin

      Complex generics, biosimilars and specialty to be growth drivers: Lupin

      Ruby Khatun Khatun11 Jun 2018 10:15 AM IST
      New Delhi: Drug firm Lupin is looking at complex generics, biosimilars and specialty medicines to be the main drivers of growth going forward,...
      India and Norway sign MoU to extend health cooperation

      India and Norway sign MoU to extend health cooperation

      Ruby Khatun Khatun11 Jun 2018 10:00 AM IST
      Ministry of Health and Family Welfare signed a Memorandum of Understanding (MoU) with the Norwegian Ministry of Foreign Affairs, Government of Norway...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok